Resources Contact Us Home
Hybrid immunoglobulin-thrombolytic enzyme molecules which specifically bind a thrombus, and methods of their production and use

Image Number 12 for United States Patent #5609869.

Hybrid immunoglobulin-enzyme molecules are provided which are composed of antibodies, or derivatives or fragments thereof, which specifically bind an arterial or venous thrombus that are operably linked to the enzymatically active portions of thrombolytic enzymes such as plasminogen activators. In a preferred embodiment the hybrid molecules specifically bind to fibrin and have fibrinolytic activity. The hybrid molecules of the present invention may be produced by any means, including chemical conjugation, or by means of recombinant DNA, genetic engineering and/or hybridoma technology. Methods for making and using the molecules in diagnosis and therapy are also disclosed.

  Recently Added Patents
Case for electronic device
Dual source mass spectrometry system
Vehicle speed verification system and method
Systems and method for automatic color plane misregistration calibration
Multilayered ceramic electronic component and fabrication method thereof
High-frequency power amplifier
Method and device for processing broadcast packets/multicast control messages
  Randomly Featured Patents
Method and apparatus for individually cooling components of electronic systems
Force-sensitive, sound-playing condom
Apparatus and method for processing radiation image
Scalable system for wide area surveillance
Method, a mechanism and a computer program product for executing several tasks in a multithreaded processor
System and method for treating a wound using ultrasonic debridement
Holder for tubular hairstyling accessories
Flexible heating wrap apparatus for charged cylinders
Method for the manufacture of recombinant unhydroxylated collagen polypeptide fibres, and recombinant unhydroxylated collagen polypeptide fibres obtained thereby
High gel strength low electroendosmosis agarose